Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1-like 2 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

The "Heterogeneous nuclear ribonucleoprotein A1-like 2 pseudogene" (ENSG00000269014) is a **pseudogene**, which means it is a DNA sequence resembling a functional gene but is generally incapable of producing a functional protein product[1][3]. Pseudogenes often arise through gene duplication or retrotransposition; they retain sequence homology to their functional counterparts but accumulate disabling mutations, such as frameshifts or premature stop codons, rendering them nonfunctional[1][3][5]. Specifically, this pseudogene is derived from a member of the heterogeneous nuclear ribonucleoproteins (hnRNPs), which are RNA-binding proteins involved in pre-mRNA processing, but the "A1-like 2 pseudogene" is not believed to encode an active protein. While many pseudogenes are "junk DNA," recent research shows some pseudogenes may have regulatory roles as long noncoding RNAs, antisense RNAs, or microRNA decoys, influencing gene expression of their parent genes or other targets[2][3][5]. However, there is no publicly available evidence that this specific pseudogene (ENSG00000269014) is functionally relevant or actively transcribed. Because pseudogenes are not considered direct therapeutic targets (they do not encode proteins or have established pathogenic functions as targets), and database convention treats entries like ENSG00000269014 as nonfunctional, **it is not a therapeutic target and is generally not considered a correct answer for molecular target queries regarding drug discovery or pharmacology**[1][3]. If you are seeking a druggable gene or protein, this entry is likely misspecified or not actionable for pharmaceutical purposes.

Other names
ENSG00000269014hnRNPA1L2 pseudogene
02

Biological functions

Possible regulatory non-coding RNA, but generally nonfunctional (see description)
03

Disease associations

Other (no direct disease associations established for this specific pseudogene)

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1-like 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1-like 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call